P3 Health Partners (NASDAQ:PIII) Stock Price Target Cut by TD Cowen

P3 Health Partners (NASDAQ:PIII) had its price target cut by stock analysts at TD Cowen from $13.00 to $4.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen‘s target price would suggest a potential upside of 21.03% from the stock’s current price.

PIII has been the topic of a number of other research reports. Weiss Ratings cut shares of P3 Health Partners from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. Lake Street Capital reissued a “buy” rating and set a $23.00 price objective on shares of P3 Health Partners in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $13.67.

P3 Health Partners Stock Performance

PIII stock traded down $0.07 during mid-day trading on Wednesday, hitting $3.31. The company had a trading volume of 9,185 shares, compared to its average volume of 408,609. The firm has a market cap of $23.99 million, a PE ratio of -0.14 and a beta of 1.81. P3 Health Partners has a 12 month low of $1.52 and a 12 month high of $16.89. The stock’s fifty day moving average price is $5.92 and its two-hundred day moving average price is $6.58.

P3 Health Partners (NASDAQ:PIII) last released its earnings results on Monday, November 9th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($3.96) by $4.03. The company had revenue of $396.34 million during the quarter, compared to analysts’ expectations of $384.95 million.

Institutional Investors Weigh In On P3 Health Partners

A hedge fund recently raised its stake in P3 Health Partners stock. Diversified Trust Co increased its position in P3 Health Partners Inc. (NASDAQ:PIII) by 73.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,289 shares of the company’s stock after buying an additional 9,849 shares during the quarter. Diversified Trust Co owned 0.32% of P3 Health Partners worth $158,000 as of its most recent filing with the Securities & Exchange Commission. 7.75% of the stock is owned by institutional investors and hedge funds.

About P3 Health Partners

P3 Health Partners Inc. is a physician-led healthcare company focused on value-based care for Medicare Advantage beneficiaries. The company works with primary care physicians, specialists, health plans and community organizations to coordinate care and improve health outcomes while addressing patients’ medical and social needs. Its services include primary care support, care coordination, chronic-condition management, preventive care, medication management and patient navigation. P3’s model uses an integrated care team and data-driven clinical programs to help physicians manage the health of senior populations across the care continuum.